The syndrome of early-delayed radiation rhombencephalopathy has been reported in five patients.'-3 Each received maximal tumour doses of about 5500 rads to tumours in or around the middle ear. In four patients, the dose fractionation and field parameters were similar and a comparable dose of radiation was delivered to the rhombencephalon: in the other patient the fractionation and field parameters were not specified. The clinical features started two to three months after completion of radiotherapy and consisted of nausea, vomiting, ataxia, dysarthria, cranial nerve palsies, internuclear opthalmoplegia and signs of corticospinal tract involvement. Three patients made a complete or partial recovery but two died within a month of onset of the illness. The necropsy2 4 of these patients revealed plaques of demyelination similar to those found in multiple sclerosis but limited to the volume of brainstem irradiated. radiation rhombencephalopathy is suggested by the necropsy findings and by the particular sensitivity of oligodendrocytes to radiation.5 The delay between radiation and the onset of the rhombencephalopathy accords well with the myelin turnover time of between five weeks and two months.6 The similarity of the clinical features of early-delayed radiation rhombencephalopathy to those of multiple sclerosis also is suggestive of a demyelinating pathogenesis.
Evoked potential studies have demonstrated both overt and subclinical demyelination in multiple sclerosis7 and similar findings might be expected following radiation-induced demyelination. We have therefore studied the visual, cortical somatosensory and brainstem auditory evoked potentials (VEP, SEP and BAEP respectively) in five patients who had received incidental radiation to their nervous system in similar doses to the reported cases of early-delayed radiation rhombencephalopathy.
Patients and methods
Five patients were studied (table 1). The tumours were irradiated by anterior-oblique and posterior-oblique fields using Cobalt-60 gamma radiation with beam trimmers (Patients 2, 4, 5) or 4MV XRs (Patients 1, 3) . The isodose treatment plan of Patients 1, 2 and 3 were similar to the We have failed to demonstrate subclinical CNS damage during the early-delayed period in patients receiving a brainstem radiation dose similar to the reported cases of early-delayed radiation rhombencephalopathy. Either the demyelination lesions of early-delayed radiation rhombencephalopathy only occur in patients with a pre-existing susceptibility or, as in the case of early-delayed radiation myelopathy'2 the lesions are not detectable by serial recordings of evoked potentials. 
